Medvic Formulations Private Limited, a active private limited company, was established on 11 April 2018 in Greater Noida, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U85300UP2018PTC103038. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Aradhana Srivastava (Director), Karuneshkumar Shivmurthilal Shrivastav (Director), Ashok Kumar Singh (Director). Past directors included Sunil Kumar Srivastava, Ashok Kumar Singh. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No. 3T - 205, Rwa, Awho Township Gurjinder Vihar, Sector Chi 1, P - 5, Greater Noida, Uttar Pradesh, 201310.
U85300UP2018PTC103038
103038
11 April 2018
₹1.00 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Medvic Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aradhana Srivastava | Director | 11 Apr 2018 | Current |
| Karuneshkumar Shivmurthilal Shrivastav | Director | 11 Apr 2018 | Current |
| Ashok Kumar Singh | Director | 02 Oct 2018 | Current |
| Sulabh Saxena | Director | 17 Jan 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Sep 2018 | Past |
| Pramod Abcsdd | Director | 06 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medvic Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 107.25% increase. The company also saw a substantial improvement in profitability, with a 120.91% increase in profit. The company's net worth Soared by an impressive increase of 362%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Medvic Formulations had a promoter holding of 90.10% and a public holding of 9.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medvic Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medvic Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medvic Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medvic Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Medvic Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was recorded as a recent event.
Progress on Sulabh Saxena was appointed as a Director was appointed as a Director on 17 Jan 2020 & has been associated with this company since 5 years 11 months . was documented.
Ashok Kumar Singh was appointed as a Director was appointed as a Director on 02 Oct 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
The activity Aradhana Srivastava was appointed as a Director was appointed as a Director on 11 Apr 2018 & has been associated with this company since 7 years 8 months . was completed.
Karuneshkumar Shivmurthilal Shrivastav was appointed as a Director was appointed as a Director on 11 Apr 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
The CIN of Medvic Formulations Private Limited is U85300UP2018PTC103038.
Medvic Formulations Private Limited is headquartered at Flat No. 3T - 205, Rwa, Awho Township Gurjinder Vihar, Sector Chi 1, P - 5, Greater Noida, Uttar Pradesh, 201310.
Medvic Formulations Private Limited was incorporated on 11 April 2018.
The current directors of Medvic Formulations Private Limited are
The primary industry of Medvic Formulations Private Limited is Trade.
Medvic Formulations Private Limited is unlisted.
The authorized capital of Medvic Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX